Paul has 18 years of experience in the healthcare sector on the sell-side and was top-rated by a
number of institutional investment clients. He was one of the first research partners at Redburn,
Europe’s leading independent research firm. His work there included bespoke projects on
healthcare portfolio construction for several institutions. Paul was previously an analyst and
corporate financier at UBS Warburg and studied biochemistry.
Brett Darke (joined 1 September 2017) has 11 years experience covering healthcare and the wider lifesciences sector on the buy-side at TT International, on both long-only and long/short funds. Brett previously worked for five years in corporate finance at Merrill Lynch and Bear Stearns. He holds and Masters degree in Medicine and Management studies from Cambridge University and is a CFA charterholder.